Skip to main content
OpenTrials

Clinical trial condition

Thrombocytopenia

Explore clinical trials studying Thrombocytopenia. Study availability and eligibility vary by location and protocol.

267 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Thrombocytopenia trial results

Completed

Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)

NCT00903422

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Santa Monica, California, United States
  • GSK Investigational Site Stanford, California, United States
  • GSK Investigational Site Coral Springs, Florida, United States
View all 65 locations
View Trial Details
Completed

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

NCT00359463

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +10 more
Locations
  • GSK Investigational Site Gainesville, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site Randwick, Sydney, New South Wales, Australia
  • GSK Investigational Site Adelaide, South Australia, Australia
View Trial Details
Completed

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

NCT01440374

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +11 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Hot Springs, Arkansas, United States
  • Novartis Investigative Site Jonesboro, Arkansas, United States
  • Novartis Investigative Site Los Angeles, California, United States
View all 120 locations
View Trial Details

Related conditions